DermTech (DMTK) Tops Q4 EPS by 3c

DermTech (NASDAQ: DMTK) reported Q4 EPS of ($0.93), $0.03 better than the analyst estimate of ($0.96). Revenue for the quarter came in at $3 million versus the consensus estimate of $2.55 million.

For earnings history and earnings-related data on DermTech (DMTK) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Hesai Group (HSAI) Tops Q1 EPS by 8c
• Noble Capital Starts Xerox (XRX) at Outperform